🇺🇸 FDA
Patent

US 8765802

Kinase inhibitors, compositions thereof, and methods of use therewith

granted A61PA61P3/10

Quick answer

US patent 8765802 (Kinase inhibitors, compositions thereof, and methods of use therewith) held by United States of America as represented by the Department of Health and Human Resources NIH expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Department of Health and Human Resources NIH
Grant date
Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P3/10